Wegorczyca [strongyloidosis]. Cz.9. Leczenie

• Autorzy: Soroczan W
• Języki publikacji: PL

Abstrakty

EN

Strongyloidosis. Part IX. Treatment. The treatment of chronic and massive (uncomplicated) and severe (complicated) disseminated srrongyloidosis, was presented from the historical point of view. The sequence of achievements in regard of treatment of the gentian violet, dithiazine iodide, benzimidazoles (thiabendazole, mebendazole, albendazole, cambendazole), ivermectin and cyclosporin A, was described. The recommendations for treatmenl of strongyloidosis are also given.

Słowa kluczowe

PL

Strongyloides stercoralis; choroby pasozytnicze; leki przeciwpasozytnicze; parazytologia; wegorek jelitowy; wegorczyca; leczenie; pasozyty

• Wydawca: -
• Czasopismo: Wiadomości Parazytologiczne
• Rocznik: 2002
• Tom: 48
• Numer: 2
• Opis fizyczny: s.173-196,bibliogr.

Twórcy

autor

Soroczan W

• Akademia Medyczna, ul.Radziwillowska 11, 20-080 Lublin

Bibliografia

• Abadie D.H., Samuels M. 1965. A fatality associated with dithiazanioe therapy. Journal of the American Medical Association 192: 326-327.
• Adam M., Morgan O., Persaud D., Gibbs W.N. 1973. Hyperinfection Syndrome with Strongyloides stercoralis in malignant lympboma. British Medical Journal 1: 264-266.
• Amato Neto V., Moreira A.A., Chiaramelli M.C, Leme J.M., Chiaramelli D.R., Campos R., Pinto P.L., De Santana E.J., Da Rocha S. 1985. Demarcagao da atividade anti-helmintica do albendazol. Estudo referente a cestrongiloidiase humana. Revista do Instituto de Medicina Tropical de São Paulo 27: 95-98.
• Amir-Ahmadi H., Braun P., Neva FA, Gottlieb L.S., Zamcheck N. 1968. Strongyloidiasis at the Boston City Hospital. Emphasis on gastrointestinal pathophysiology and successful therapy with thiabendazole. American Journal of Digestive Diseases 13: 959-973.
• Archibald L.K., Beeching N.J., Gill G.V., Bailey J.W., Bell D.R. 1993. Albendazole is effective treatment for chronic strongyloidiasis. Quarterly Journal of Medicine 86: 191-195.
• Arroyo J.C., Brown A. 1987. Concentrations of thiabendazole and parasite specilic IgG antibodies in the cerebrospinal fluid of a patient with disseminated strongyloidiasis. Journal of Infectious Diseases 156: 520-523.
• Asshauer E., Mohr W. 1966. Thiabendazol in der Behandlung von Wurminfektion. Arzneimittelforsch 16: 428-431.
• Aziz E.M. 1969. Strongyloides stercoralis infestation: review of the literature and report of 33 cases. Southern Medical Journal 62: 806-810.
• Baranski M.C., Da Silva A.F., Kotaka P.I., Gomes N.R., Giovannoni M., Teiles J.E. 1978. Tratamento da estrongiloidiase humana com novo anti-helmintico, o cambendazole. Estudo duplo cego. Revista do Instituto de Medicina Tropical de São Paulo 20: 213-218.
• Baranski M.C., Da Fontoura A., Guimares L.M. 1981. Tratamiento de las helminthiases intestinales con albendazole, un nuevo antihelmintico del grupo de los benzimidazoles. Estudo doble ciego. Compedium de Investigaciones Clinicos Latino Americanos, Supplement 1: 82-89.
• Bartholomew C., Butler A.K., Bhaskar A.G., Jankey N. 1977. Pseudoobstruction and a sprue-like syndrome from strongyloidiasis. Postgraduate Medical Journal 53: 139-142.
• Berger R., Kraman S., Paciotti M. 1980. Pulmonary strongyloidiasis complicating therapy with corticosteroids. Report of a case with secondary bacterial infections. American Journal of Tropical Medicine and Hygiene 29: 31-34.
• Berk S.L., Verghese A., Alvarez S., Hall K., Smith B. 1987. Clinical and epidemiologic features of stroogyloidiasis in rural Tennessee. Archives of Internal Medicine 147: 1257-1261.
• Bezjak B.A. 1968. A clinical trial of thiabendazole in stroogyloidiasis. American Journal of Tropical Medicine and Hygiene 17: 733-736.
• Bicalbo S.A., Leao O.J., Pena Q. 1983. Cambendazole in the treatment of human strongyloidiasis. American Journal of Tropical Medicine and Hygiene 32: 1181-1183.
• Boken D.J., Leoni PA, Preheim L.C. 1993. Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. Clinic of Infectious Diseases 16: 123-126.
• Boram L.H., Keller K.F., Justus D.E., Collins J.P. 1981. Strongyloidiasis in immunosuppressed patients. American Journal of Clinical Pathology 76: 778-781.
• Botero D. 1964. Report on clinical investigations with thiabendazole. Tribuna Medica 3: 1-8.
• Botero D. 1965. Treatment of human intestinal helminthiases with thiabendazole. American Journal of Tropical Medicine and Hygiene 14: 618-621.
• Boyd W.P., Campbell F.S., Trudeau W.L. 1978. Strongyloides stercoralis – hyperinfection. American Journal of Tropical Medicine and Hygiene 27: 39-41.
• Brasitus R.A., Gold R.P., Kay R.H., Magun A.R., Lee W.M. 1980 Intestinal strongyloidiasis. A case report and review of the literature. American Journal of Gastroenterology 73: 65-69.
• Brown H.D., Matzuk A.R., Ilves J.R., Peterson L.H, Harris S.A. 1961. Antiparasitic drugs. N-2-(4'thiazolyl)-benzimidazole, a new anthelmintic. Journal of American Chemical Society 83: 1764-1765.
• Brown H.W., Sterman M.M. 1958. Chemotherapy of strongyloidiasis with pyrrovinylquinium (Vanquin). American Journal of Tropical Medicine and Hygiene 7: 253-256.
• Brugmans J.P., Thienpont D.S., Van Wijngaarden I., Vanparijs O.F., Schuermans V.L, Lauwers H.L. 1971. Mebendarole in enterobiasis: radiochemical and pilot clinical study in 1.278 subjects. Journal of the American Medical Association 217: 313-316.
• Bueding E., Hawkins J., Cha Y.N. 1981. Antischistosomal effects of cyclosporin A. Agents and Actions 11: 380-383.
• Cahill K.M. 1967. Thiabendazole in massive strongyloidiasis. American Journal of Tropical Medicine and Hygiene 16: 451-453.
• Camilo-Coura L., De Velho Soli A.S., Lima Dos Santos N., De Castro Peixotoa T.H., Willcox H.P. 1981. Tratamiento de las helminthiasis intestinales con albendazol un deriviadao benzimidazolico nuevo-estudo doble ciego. Compendium de Investigaciones Clinicos Latino Americanos 67-74.
• Campbell W.C. 1985. Ivermectin: an update. Parasitology Today 1: 10-16.
• Campbell W.C., Cucler A. 1969. Thiabendazole in treatment and control of parasitic infections in man. Texas Report of Biology and Medicine. 27(Suppl. 2): 665-692.
• Carrie J. 1968. Activiti du thiabendazole dans le traitement de la strongiloidose. 8e Confirence Technicale, OCCGE, Bamaco, Haute Volta 424-428.
• Cavier R. 1973. Chemotherapy of intestinal nematodes. In: Chemotherapy of Helminthiases (Eds. R. Cavier and F. Hawking). Oxford Pergamon Press, 215-436.
• Chaia G., Da Cunha A.S. 1966. Novo escuema terapeutico dom o tiabendazole na esuongiloidiase humana. Revista do Instituto Medicina Tropical de São Paulo 8: 173-176.
• Chaia G., Da Cunha A.S. 1971. Therapeutic action of mebendazole (R 17635) against human helminthiasis. Folha Medica 63: 843-852.
• Cherin E. 1954. Diethylocarbamazine in the treatment of strongyloidiasis. Journal of Parasitology 40: 589-590.
• Chongsuphajaisiddhi T., Sabcharoen A., Attanath P., Panasoponkul C., Radomyos P. 1978. Treatment of soil-transmitted nematode infections in children with mebendazole. Annals of Tropical Medicine and Parasitology 72: 59-63.
• Chowdury A.B., Bandyopadhyay A.K., Banerjee M. 1964. Preliminary observations on the clinical trial of thiabendazole against human helminthiasis. Bulletin of the Calculla School of Tropical Medicine 12: 124-125.
• Coene A. 1969. Rappon sur le traitment des helmithiases par je levo-tetramisole chez les malades hospitalisie a l'htspital giniral de Bukava. Janssen Pharmaceutica Clinical Research Report N 522.
• Cookson J.B., Montgomery R.D., Morgan H.V., Tudor R.W. 1972. Fatal paralytic ileus due to stroogyloidiasis. British Medical Journal 15: 771-772.
• Coulaud J.P., Deluol A.M., Cenac J ., Rossignol J.F. 1982. L'albendazole dans le traitment de la strongyloidose. A propos de 66 observations. Bulletin de la Socete de Pathologie Exotique 75: 530-533.
• Coulaud J.P, Mergier Y., Tessier S., Mechali D. 1980. Analyse epidemiologique, clinique et therapeutique de 427 cas d'anguilluloses observe a Paris. Bulletin de la Socete de Pathologie Exotique 73: 100-108.
• Croce J.R, Capos V., Amato-Neto V., Diase De Avila Pires C., Campos Martins A.C., Laurenti R., Mello Alburquerque F.J. 1963. Tratamento da estrongiloidiase pelo tiabendazole. Revista do Instituto Medicina Tropical de São Paulo 5: 194-197.
• Cruz T., Reboucas G., Rocha H. 1966. Fatal strongyloidiasis in patients receving corticosteroids. New England Journal of Medicine 275: 1093-1096.
• Cuni LJ., Rosner F., Chawla S.K. 1977. Fatal strongyloidiasis in immunosuppressed patients. New York State Journal of Medicine 77: 2109-2113.
• Cunliffe W.I., Silva L.G. 1968. Linear urticaria due to larva currens -strongyloidiasis. British Journal of Dermatology 80: 108-110.
• Datry A., Hilmarsdottir I., Mayorga-Sagastuma R., Lyagoubi M., Gaxotte P., Billigui S., Chodakewitz J., Neu D., Danis M., Geotilini M. 1994. Treatment of Strongyloides stercoralis infection with albeodazole: results of an open study of 60 cases. Transactions of the Royal Society of Tropical Medicine and Hygiene 88: 344-345.
• De Langen C.D. 1928. Anguillosis en hat ziektebeeld van de "idiopathische hypereosinophille". Geneeskundig Tijdschrift Nederlandsch Indie 68: 973-990.
• De Langen C.D. 1929. Postscript about anguillosis and eosinophilia. Mededeelingen van den Dienst der Volksgezondheid in Nederlandsch Indie 18: 310-314.
• Demoen P., Van Aelst C., Loomans J., De Verbaegen H., Cree I ., Verbruggen F., Ringoir S. 1973. The absorption and urinary excretion of mebeodazole afier oral administration. Janssens Pharmaceutica, Clinical Research Repot R 17635/36.
• De Oliveira Gomez M.C. 1977. Tratamento da estroogiloidiase pelo cambendazole. Fölha Medica 74: 315-337.
• Deschiens R., Benex J. 1957. Essais experimentaux et cliniques de traitement de l'anguillulose intestinale par le sous-nitrate et par carbonate de bismuth. Bullerin de la Socitre de Pathologie Exotique 50: 70-74.
• De Vault G.A., Brown S.T., Montoya S.F., King J.W., Rohr M.S., McDonald J.C. 1982. Disseminated strongyloidiasis complicating acute renal allograft rejection. Prolonged thiabendazole and successful retransplantation. Transplantation 34: 220-221.
• Doeglas H.M., Berg J.A. 1972. Larva currens (migrans) caused by Srrongyloides stercoralis. Dermatologica 144: 350-352.
• Domart A., Gentilini M., Therizol M., Carbon A 1967. Traitement de la strongyloidose par le thiabendazole (A propos de 100 cas). Societe Medicale des Hospitaux de Paris 118: 1047-1050.
• Dwork K.G., Jaffe J.R., Lieberman 11.D. 1975. Strongyloidiasis with massive hyperinfection. New York State Medical Journal 15: 1230-1234.
• Egerton J.R. Campbell W.C. 1970. The efficacy of 5-isopropoxycarbonylamino-2-(4-thiazolyl)benzimidazole against helminths in sheep. Research in Veterinary Science 11: 193-195.
• Escobar A.J. 1964. Tiabendazole un nueva antihelmmtico de amplio espectro. Antioquia Medicina 14: 369 387.
• Ford J., Reiss-Levy E., Clark E., Dyson A.J., Schonell M. 1981. Pulmonary strongyloidiasis and lung abscess. Chest 19: 239-240.
• Fowler C.G., Lindsay 1., Lewin J, Swenty P., Fernando O.N., Moorbead J.F. 1982. Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft patient. British Medical Journal 11: 1394.
• Franz K.11. 1963. Clinical trials with thiabendazole against human strongyloidiasis. American Journal ol Tropical Medicine and Hygiene 12: 211-214.
• Franz K.H., Schneider W.J., Pbolman M.H. 1965. Clinical trials with thiabendazole against intestinal nematodes infecting human. American Journal ol Tropical Medicine and Hygiene 14: 383-386.
• Friedman P.A., Platzer E.G. 1978. Interaction of anthelmintic benzimidazole and benzimidazole derivatives with bovine brain tubulin. Biochimica et Biophysica Acta 630: 271-278.
• Gann P.H, Neva F.A, Gam A.A. 1994. A randomized trial of single and two dose ivermectin versus thiabendazole for treatment of strongyloidiasis. Journal ol Infectious Diseases 169: 1076-1079.
• Gatti F., Krubwa F., Lontie M., Vandepitte J., Thieopont D. 1972. Clinical experience with mebendazole, a new broad-spectrum anthelminuc. Advances Antimicrobial and Antineoplastiic Chemotherapy, Urban, Schwarzenberg.
• Gentilini M. 1974. Expertise clinique du mebendazole. Janssen Pharmaceutica Clinical Research Report N 8247.
• Gladenko V J. 1973. Funlccionalno-morfologicheskoe narushenija nekotorykh voutrennykh organov i terapeuticheskaja aktivnost tiabendazola pri strongiloidoze. Avtoreferat Dissertacija Kandidatskaja, Charkov.
• Gomez-Ferrar W. 1963. Tratamento da estrongiloidiase e da ascaridiase com thiabendazole. O Hospital 64: 1381-1388.
• Gompels M.M., Todd J., Peters B.S., Main J., Pinching AJ. 1991. Disseminated stroogyloidiasis in AIDS: uncommon but important AIDS 5: 329-332
• Gordon H. 1961. Thiabendazole: a highly effective anthelmintic for sheep. Nature 191: 1409-1410.
• Grassi G.B. 1883. Un ultra nota sulle anguillule e sugli anchilostomi. Giornale della Reale Academia di Medicina di Torino 31: 119-121.
• Grove D. I. 1982a. Strongyloides ratti and S. stercoralis the effects of thiabendazole, mebendazole and cambendazole in infected mice. American Journal ol Tropical Medicine and Hygiene 31: 469-476.
• Grove D.I. 1982b. Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness. Transactions of the Royal Society of Tropical Medicine and Hygiene 16: 114-118.
• Grove D.I. 1983. Effects of 22, 23-dihydroavermectin B1 on Strongyloides ratti and S. stercoralis infections in mice. Annals of Tropical Medicine and Parasitology 71: 405-410.
• Grove D.I. 1989. Treatment. In: Strongyloidiasis· A major roundworm infection of man. (Ed. D.I. Grove) Taylor and Francis. London. New York. Philadelphia.
• Grove D.I, Lumsden J., Northern C. 1988. Efficacy of albendazole against Strongyloides ratti and S. stercoralis in vitro, in mice, and in normal and immunosuppresscd dogs. Journal of Antimicrobial Chemotheropy 21; 75-84.
• Grove D.I., Northern C. 1986. Strongyloides ratti and S. stercoralis; effects of cambendazole, thiabendazole and mebendazole in vitro. Revista do Instituto Medicina Tropical de São Paulo 28: 97-103.
• Grove D.I , Northern C. 1988. The effects of thiabendazole, mebendazole and cambendazole in normal and immunosuppressed dogs infected with a human strain of Strongyloides stercoralis. Transactions of the Royal Society of Tropical Medicine and Hygiene 82: 146-149.
• Harris R.A., Musher D.M., Fainstein V., Young E.J., Clarridge J. 1980. Disseminated strongyloidiasis. Diagnosis made by sputum examination. Journal of the American Medical Association 244: 65-66.
• Hoff D.R., Fisher M.H., Bochis B.J., Lusi A, Waksmunski F., Egerton J.R., Yakstis J.J., Cuckler A.C, Campbell W.C. 1970. A new broad-spectrum anthelmintic 2-(thiazolyl)-5-sopropylcarbonylamino-benzimidazole. Experientia 26: 550-551.
• Hogg R.A. 1978. Death after cambendazole dosing. Veterinary Record 103: 477.
• Hoy W.E., Roberts NJ., Bryson M.F., Bowles C, Lee J.C., Rivero A.J., Ritterson A.L. 1981. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. Journal of the American Medical Association 246: 1937-1939.
• Huggins D. 1979. Cambendazole -nova substancia para o tratamento da estrongiloidiase. G. E. N. (Venezuela) 33. 301-305.
• Igra-Siegman U., Kapila R., Sen P., Kaminski Z.C., Louria D.B. 1981. Syndrome of hyperinfecuon with Strongyloidies stercoralis. Reviews of Infectious Diseases 3: 397-407.
• Ireland M., Gutteridge W.E., Pogson C.l 1979 The interaction of benzimidazole carbamates with mammalian microtubule protein. Biochemical Pharmacology 28: 2680-2682.
• Isebaert A. 1970. Essai therapeutique avec le R 17535 et son association avec le levamisole. Janssen Pharmaceutica Clinical Research Report N 4694.
• Ishmukhametov AJ. 1964. K sravnitelnoj kharakteristike gencjanvioleta i dihazanina pri lechenii strongiloidoza. Medicinskaja Parazitologija i Parazitarnyje Bolezni 33: 419-422.
• Janssens P.G. 1986. Chemotherapy of gastrointestinal nematodiasis in man. In: Chemotherapy of gastrointestinal helminths (Eds. H. Vanden Bossche, D. Thienpont and P.G. Janssen). Berlin Springer-Verlag.
• Janssens P.G., De Muynck A, D'Arenberg S. 1966. Thiabendazole, een opzienbarernd nieuw wormfdrijvend middel. Annales de la Societt Beige de Medecine 46: 397-420.
• Johns D.J., Philip J.R. 1977. Albendazole: safety in sheep. Abstract paper. Eight International Conference for the Advancement of Veterinary Parasitology, Sydney.
• Jorge J., Barbosa W. 1964. Tratamento da estrongjloidiase pelo lhiabedazole. Revista Gioana de Medicina 10: 135-140.
• Köhler P., Bachman R. 1981. Intestinal tubulin as possible target for the chemotherapeutic action of mebendazole in parasitic nematodes. Molecular and Biochemical Parasitology 4: 325-336.
• Kołodziejczyk L, Sulżyc-Bielicka V., Kuźna-Grygiel W., Bielicki D., Stępień -Korzonek M., Szmatłoch E. 2000. A clinical case of infection with Strongyloides stercoralis. Acta Parasitologica 45: 241.
• Krotov A.I., Kolosova M.O, Timosbin D.G. 1960. Izuchenie antgelmintnoj aktivnosti otechestvennogo i zarubezhnogo ditiazanina (3-3'-dietiltiadikarbocianinjodida) pri gelmintozach laboratornych zhivotnych. Medicinskaja Parazitologija i Parazitarnyje Bolezni 29: 647.
• Krotov A.I., Bajandina D.G., Chernjaeva A.I. 1978. Mebendazol (Vermox) -novyj antigelmintik shirokogo spectra dejstvija. Medicinskaja Parazitologija i Parazitarnyje Bolezni 2: 48-54.
• Krubwa F., Gatti F., Lontie M., Ngute K.., Vandepitte J., Thienpont D. 1974. Administration trimestrielle de mebendazole en milieu scolaire suburbaine. Medecine Tropicale 34: 679-687.
• Kudiche R. 1925. Neue Verfahren zu Untersuchung und Prufung von WurmmiteIn. Versuch an Finnen und Strongyloideslarven. Archiv für Schiffs und Tropen Hygiene 29: 189-197.
• Leapman S.B., Rosenberg J.B., Filo R.S., Smith E.J. 1980. Strongyloides stercoralis in chronical renal failure: safe therapy with thiabendazole. Southern Medical Journal 73: 1400-1402.
• Liepman M. 1975. Disseminated Strongyloides stercoralis. A complication of immunosuppression. Journal of the American Medical Association 231: 387-388.
• Loria Cortez R., Lizano C., Chavaria A.O., VillaVicencio N., Calzada Castro L.D. 1974. Experience with mebendazole in children with multiple intestinal helminthiasis. Janssen Pharmaceutica Clinical Research Report N 7327.
• Lyagoubi M., Datry A., Mayorga R., Brucker G., Hilmarsdottir I., Gaxotte P., Neu D., Danis M., Genlilini M. 1992. Chronic persistent strongyloidiasis cured by ivermectin. Transactions of the Royal Society of Tropical Medicine and Hygiene 86: 541.
• Main D.C., Vass D.E. 1980. Cambendazole toxicity in calves. Australian Veterinary Journal 56: 237-238.
• Maisooneuve H., Piens M.A., Mojon M., Garin J.P. 1981. L'albendazole. Evaluation de la tolerance de l'efficacite dans l'oxyurose, La trichocephalose, l'ankylostomose, l'ascaridiose et l'anguillulose. Bulletin de la Societe de Pathologie Exotique 74: 443-444.
• Mansfield L.S., Schad G.A. 1992 Ivermectin treatment of naturally acquired and experimentally induced Strongyloides stercoralis infection in dogs. Journal of the American Veterinary Medical Association 201: 726-730.
• Marti H., Haji H.J., Savioli L., Chwaya H.M., Mgeni A.F., Ameir J.S., Hatz C. 1996. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil transmitted helminth infections in children. American Journal of Tropical Medicine and Hygiene 55: 477-481.
• Martirani I., Rodrigues L.D. 1976. Ensaio clinico com o cambendazole, uma nova droga na terapeutica anti-helmintica (nota previa). Revista do Instituto Medicina Tropical de São Paulo 18: 71-75.
• McCracken R.O., Stillwell W.H., Hudson H.M. 1982. A possible biochemical mode of action of benzimidazole anlhelmintics. Molecular and Biochemical Parasitology Supplement 726.
• Melashenko V. 1963. Izuchenie dejstvia nekotorych vneshnich faktorov na lichinki Strongyloides stercoralis. Medicinskaja Parazitologija i Parazitarnyje Bolezni 32: 163-168.
• Meltzer R.S., Singer C., Armstrong D., Mayer K., Knapper W.H. 1979. Antemorten diagnosis of central nervous system stroogyloidiasis. American Journal of the Medical Sciences 277: 91-98.
• Mikulski R. 1954. Choroba węgorzykowa na terenie województwa krakowskiego i własne spostrzeżenia dotyczące biologii węgorzyka. Polski Tygodnik Lekarski 9: 469-472.
• Mojon M., Melet V., Duraod-Peyre F., Jacquet F. 1981. Anguillulose et albendazole. Mise au point des contrtles post therapeutiques. Lyon Medicale Supplement 245: 99-104.
• Mojon M., Piens M.A. 1982. L'albendazole et anguillulose. Medecine d'Afrique Noire 29: 9-14.
• Morgan J.S., Schaffner W., Stone W.J. 1986. Opportunistic strongyloidiasis in renal transplaot recipients. Transplantation 42: 518-524.
• Moskalenko J.K.. 1959. Lechenie strongiloidoza gencjanvioletom v sochetanii s diatermoj. Avtoreferat Dissertacija Kandidatskaja, Charkov.
• Most H, Yoeli M., Campbell W.C., Cuckler A.C. 1965. The treatment of Strongyloides and Enterobius infectioos with thiabendazole. American Journal of Tropical Medicine and Hygiene 14: 379-382.
• Mravak S., Schopp W., Bienzle U. 1983. Treatment of strongyloidiasis with mebendazole. Acta Tropica 40: 93-94.
• Munst G.J., Kalaganis G., Bircher J. 1980. Plasma concentrations of mebendarole during treatment of echinococcosis. Preliminary results. European Journal of Clinical Pharmacology 17: 375-378.
• Musgrave I.A., Hawes R.B., Jameson J.L., Sloane R.A., Quayle P.A. 1979. Mebendazole. Evaluation of a new anthelmintic for trichuriasis, bookworm and strongyloidiasis. Medical Journal of Australia 1: 403-405.
• Narasimhan N., Piering W.f., Kaulfman H.M., Lemann J. 1983. Letter to the editor. Transplantation 36: 472
• Nauenberg W., Edelman M.H., Spingarn C.L. 1970. Observations of treatment of strongyloidasis with thiabendazole in New York City. Mount Sinai Journal of Medicine 37: 607-611.
• Normand L. 1876. Sur la maladie dite diarrhie de Cochinchine. (Extrait d'une lettre adressee a M. le President par M. le viceamiral Jurien de la Graviere). Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 83: 316-318.
• Nwokolo C., Imobiosen E.A. 1973. Strongyloidiasis of respiratory tract presenting as "asthma". British Medical Journal 11: 153-154.
• Ozereckovskaja N., Linevich O., Karnaukhov V. 1971. Effektivnost i perenosimost tiabendazola pri strongiloidoze i linejnom dermatite. Medicinskaja Parazitologija i Parazitarnyje Bolezni 40: 346-350.
• Panyantha R., Sriumpa S., Tantranod R. 1983. Fatal strongyloidiasis in Siriraj Hospital, Bangkok, Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 14: 294-297.
• Pelletier L.L., Baker C.B. 1987. Treatment failures following mebendazole therapy for chronic strongyloidiasis. Journal of Infectious Diseases 156: 532-533.
• Peña Chavarria A., Swartzwelder J.C., Villarejos V .M., Zeledon R. 1973. Mebendazole, an effective broad-spectrum anthelmintic. American Journal of Tropical Medicine and Hygiene 22: 592-593.
• Pene P., Mojon M., Garin J.P., Couland J ., Rossignol J.F. 1982. Albendazole: a new broad spectrum anthelmintic. Double-blind multicenter clinical trial. American Journal of Tropical Medicine and Hygiene 31: 263-266.
• Pene P., Vicentelli J.M., Soula G., Bourderioux C.H., Rossignol J.F. 1981. Le zentel (albendazole) dans le traitement des nimatodiases intestinales. Etude multicentrique en Afrique de l'Ouest. A propos de 390 observations. Medecine d'Afrique Noir 28: 483-485.
• Penicaut B., Maugcin P., Maisonneuvc H., Rossignol J.F. 1983. Pharmacocinetique et metabolisme urinaire de l'albendazole chez l'höme. Bulletin de la Societe de Pathologie Exotique 76: 698-708.
• Perroncito E. 1880. Osservazioni elmintologiche relative alla malattia sviluppatasi endemica negli i operai del Gothardo. Attico Revista dell'Accademia Scienze Fisico-Matematico-Natural, Roma 7: 381-433.
• Persaud C.R., Grant L.S. 1972. In vitro comparison of the activity of Mintezol and Ketrax against Strongyloides stercoralis. Transactions of the of Tropical Medicine and Hygiene 66: 368-369.
• Prichard R.K. 1970. Mode of action of the anthelmintic thiabendazole in Haemonchus contortus. Nature 228: 684-685.
• Prokhorov A.F., Isupov J. 1978. Sluchaj smerti ot strongiloidoza na fone naznachenija kortikosteroidov. Medicinskaja Parasitologija i Parazitarnyje Bolezni 47: 103-104.
• Pungpak S., Bunnag D., Chindanon D., Radmovos B. 1987. Albendazole in the treatment of strongyloidiasis. Southeast Asian Journal of Tropical Medicine and Public Health 18: 207-209.
• Ramalingam S., Sinniah B., Krisbnan U. 1983. Albendazole, an effective single dose, broad spectrum anthelmintic drug. American Journal of Tropical Medicine and Hygiene 32: 984-989.
• Rivera E., Maldonado N., Velez-Garcia E., Grille AJ., Malaret G. 1970. Hyperinfection syndrome with Strongyloides stercoralis. Annals of Internal Medicine 72: 199-204.
• Robinson R.D., Williams L.A., Lindo J.F., Terry S.I., Mansingh A. 1990. Inactivation of Strongyloides stercoralis filariform larvae in vitro by Jamaican plant extracts and three commercial anthelmintics. West Indies Medicine Journal 39: 213-217.
• Rodrigues L.D., Martirani I., Cabeca M., Soares W., Brandao J.A. 1977. Cambendazol: novo anti-helmintico na terapeutica da estrongiloidase. Experimentagao clinica. Revista do Instituto de Medicina Tropical de São Paulo 19: 57-57.
• Rodriguez Da Silva J., Camillo-Coura L., Tinoco De Carvalbo H., Almeida-Lopes P.F. 1968. Tratamento da estrongyloidiase. Resultados preliminares de ensaio com un novo antihelmintico o thiabendazole. O Hospital 63: 247-264.
• Rossignol J.F. 1981. Albendazol: estudios clinicos realizados en Francia y Africa Occidental. Informe sobore 1.034 casos. Ist Simposium Latino-Americano de Geohelminthiasis y Albendazole. Compendium de Invesligaciones Clinicos Latino-Americanos, Cancum, Mexico 114-125.
• Rossignol J.F., Maisonneuve H. 1983. Albendazole: placebo-controlled study in 870 patients with intestinal helminthiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 77: 707-711.
• Royle G., Fraser-Moodie A., Wansbrough Jones M. 1974. Hyperinfection with Strongyloides stercoralis in Great Britain. British Journal of Surgery 61: 498-500.
• Shablovskaja E. A.1986. Strongiloidoz. Medicina, Moskva.
• Saimot A.G., Meulemans A., Cremieux A.C., Giovanangeli M.D., Hay K.M., Delaitre B., Coulaud J.P. 1983. Albendazole as potential treatment for human hydatidosis. Lancet 11: 652-656.
• Schad G.A. 1986. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patiens. Journal of Infectious Diseases 153: 1768.
• Schumaker J.D., Band J.D., Lensmeyer G.L., Craig W.A. 1978. Thiabendazole treatment of severe strongyloidiasis in a haemodialyzed patient. Annals of Internal Medicine 89: 644-645.
• Scoggin C.H., Call N.B. 1977. Acute respiratory failure due to disseminated strongyloidiasis in a renal transplant recipient. Annals of Internal Medicine 87: 456-458.
• Scowden E.B., Schaffner W., Stone W.J. 1978. Owerwhelming strongyloidiasis; an unappreciated opportunistic infection. Medicine (Baltimore) 57: 527-544.
• Seabury J.H., Abadie S., Savoy F. 1971. Pulmonary strongyloidiasis with lung abscess. Ineffectiveness of thiabendazole therapy. American Journal of Tropical Medicine and Hygiene 20: 209-211.
• Shafei A.Z. 1974. Clinical trials of mebendazole in the treatment of intestinal nematodes. Janssen Pharmaceutica Clinical Research Report N 8165.
• Shafei A.Z. 1976. Clinical trials of mebendazole in the treatment of strongyloidiasis. Janssen Pharmaceutica Clinical Research Report M 10494.
• Shelhamer J.H., Neva F.A., Finn D.R. 1982 Persistent strongyloidiasis in an immunodeficient patient American Journal of Tropical Medicine and Hygiene 31: 746-751.
• Smith B., Verghese A., Guiterrez. C., Dralle W., Berk S.L. 1985. Pulmonary strongyloidiasis: diagnosis by sputum Gram stain. American Journal of Medicine 79: 633-666.
• Soroczan W. 1977. Dzialanie wybranych chemioterapeutyków, środków dezynfekcyjnych i nawozów sztucznych na przeżywalność larw Strongyloides stercoralis (Nematoda, Strongyloididae). Annales Universitalis Mariae Curie-Sklodowska, Sectio D 32: 215-220.
• Stemmermann G.N., Nakasone N. 1960. Strongyloides stercoralis infestation: malabsorption defect with reaction to dithiazanine iodide. Journal of the American Medical Association 174: 1250-1253.
• Stone O.J., Newell G.B., Mullins J.F. 1972. Cutaneous strongyloidiasis: larva currens. Archives Dermatology 106: 734-736.
• Stone W.J., Schaffner W. 1990. Strongyloides infections in transplant recipiens. Seminars in Respiratory Infeclions 5: 58-64.
• Swartzwelder J.C., Frye W.W., Mubleisen J.P., Miller J.H., Pena-Chavarria A.A., Abadie S.H., Anthony S.O., Sappanfield R.W. 1957. Dithiazanine, an effective broad spectrum anthelmintic. Journal of the American Medical Associalion 165: 2063-2067.
• Theodorides V.J., Gyurik R.J., Kingsbury W.D., Parisk R.C. 1976. Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundworms. Experientia 32: 702.
• Thomson A.W., Smith S.W., Chappell L.H. 1986. Cyclosporin A: immune suppressant and anti-parasitic agent Parasitology Today 2: 288-290.
• Tikhomirova E.P., Prokhorov A.F. 1978. Opyt primenenija vermoksa (mebendazola) dla lechenija bolnych strongiloidozom. Medicinskaja Parazitologija i Parazitarnyje Bolezni 47: 26-28.
• Tikhomirova E.P., Prokhorov A.F. 1983. Osobennosti kliniki i lecbenija strongiloidoza v zavisimosli ot gruppovoj prinadlezhnosti krovi bolnych po sisteme ABO (H). Medicinskaja Parazitologija i Parazitarnyje Bolezni 52: 22-26.
• Tocco D.J., Egerton J.R., Bowerrs W., Christensen V. W., Rosenblum C. 1965. Absorption, rnetabolism and elimination of thiabendazole in farm animals and a method for its estimation in biological materials. Journal of Pharmacology and Experimental Therapeuties 149: 263-270.
• Tocco D. J., Rosenblum C., Martin C., Robinson H.J. 1966. Absorption, metabolism and excretion of thiabendazole in man and laboratory animals. Toxicology and Applied Pharmacology 9: 31-39.
• Torres J.R., Isturiz R., Murillo J., Guzman M., Contreras R. 1993. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clinical of Infectious Diseases 17: 900-902.
• Vandnen Bossche H., De Nollin S. 1973. Effects of mebendazole on the absorption of low molecular weigbt nutrients by Ascaris suum. International Journal for Parasitology 3: 401-407.
• Vandnen Bossche H., Rochette F., Hering C. 1982. Mebendazole and related anthelmintics. Advances in Pharmacology and Chemotherapy 19: 67-128.
• Venizelos P.C., Lopata M., Bardawil W.A., Sharp J.T. 1980. Respiratory failure due to Strongyloides stercoralis in a patient with a renal transplanl Chest 78: 104-106.
• Vilela M.P., Rodrigues L.D., Capell J.I., Brandao J.A., Martirani L, Zacato M. 1962 O emprego di tiabendazol no tratamento da estrongiloidiase de outras parasitosis humanas. O Hospital 62: 691-710.
• Vishwanath S., Baker R.A., Mansheim B.J. 1982. Strongyloides infection and meningitis in an immunocompromised host American Journal of Tropical Medicine and Hygiene 31: 857-858.
• Wachter R.M. Burke A.M., McGregor R.R. 1984. Strongyloides stercoralis hyperinfection masquerading as cerebral vasculitis. Archives of Neurology 41: 1213-1216.
• Walker-Smith J.A., McMillan B., Middleton A.W., Robertson S., Hopcroft A. 1969. Strongyloidiasis causing small-bowel obstruction in an aboriginal infant. Medical Journal of Australia 11: 1263-1265.
• Waller P.J., Prichard R.K. 1986. Drug resistance in nematodes. In: Chemotherapy of Parasitic Diseases (Eds. C. Cambell and R.S. Rew). New York Plenum Press, 339-362
• Weller I.V., Copland P., Gabriel R. 1981. Strongyloides stercoralis in renal transplant recipients. British Medical Journal 1: 524.
• West B.C., Wilson J.P. 1980. Subconjunctival corticosteroid therapy complicateted by hyperinfective strongyloidiasis. American Journal of Ophthalmology 89: 854-857.
• Wędrychowicz H. 1996a. Występowanie, mechanizmy i metody wykrywania lekooporności nicieni żołądkowo-jelitowych owiec i kóz. Lek w Polsee (Weterynaria) 13: 2-13.
• Wędrychowicz H. 1996b. Występowanie oraz mechanizmy lekooporności przywr i nicieni pasożytniczych u zwierząt roślinożernych. Medycyna Weterynaryjna 52: 494-497.
• Willis A.I., Nwokolo C. 1966. Steroid therapy and strongyloidiasis. Loncet 1: 1396-1398.
• Wilson K.H., Kauffman C.A. 1983. Persistent Strongyloides stercoralis in a blind loop of bowel. Successful treatment with mebendazole. Archives of Internal Medicine 143: 357-358.
• Zyngier F., Lemme A.C., Pereira E.G., Leal B.B., Liberal M.H. 1983. Surgical perpetuation of serious infection with Strongyloides stercoralis. Transactions of the Royal Society of Tropical Medicine and Hygiene 77: 425.